Long Focus Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,098,000
| Closed | -$393K | – | 97 |
|
|
2024
Q2 | $393K | Hold |
1,098,000
| – | – | 0.02% | 80 |
|
|
2024
Q1 | $736K | Sell |
1,098,000
-274,000
| -20% | -$184K | 0.04% | 76 |
|
|
2023
Q4 | $745K | Hold |
1,372,000
| – | – | 0.02% | 82 |
|
|
2023
Q3 | $823K | Buy |
1,372,000
+100,000
| +8% | +$60K | 0.03% | 76 |
|
|
2023
Q2 | $1.65M | Buy |
1,272,000
+200,000
| +19% | +$260K | 0.08% | 62 |
|
|
2023
Q1 | $1.89M | Hold |
1,072,000
| – | – | 0.11% | 64 |
|
|
2022
Q4 | $3.37M | Buy |
1,072,000
+542,000
| +102% | +$1.7M | 0.23% | 49 |
|
|
2022
Q3 | $2.6M | Hold |
530,000
| – | – | 0.25% | 48 |
|
|
2022
Q2 | $2.19M | Buy |
530,000
+190,000
| +56% | +$787K | 0.23% | 59 |
|
|
2022
Q1 | $1.98M | Buy |
340,000
+95,000
| +39% | +$552K | 0.25% | 54 |
|
|
2021
Q4 | $1.84M | Buy |
+245,000
| New | +$1.84M | 0.24% | 49 |
|